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The merits of the suggestion that Cu, in cytochrome oxidase is a mixed-valence binuclear site is reviewed on the basis of recent analytical and 
spectroscopic studies. First an alternative mononuclear model is presented. Metal analyses indicate that homogeneous oxidase preparations with 
high activity contain 3Cu/2Fe. Multifrequency EPR measurements demonstrate a close similarity with a copper site in nitrous oxide reductase, 
and this is also supported by optical and MCD spectra. Strong evidence for a binuclear site is provided by a 7-line hyperfine structure in the EPR 
spectra of both enzymes. A binuclear model consistent with amino acid sequence data can be formulated. 
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1. INTRODUCTION 
Keilin suggested in 1938 already that cytochrome ox- 
idase is a copper protein, but with the discovery of 
cytochrome a3 in the following year the possible func- 
tional involvement of copper was largely ignored (see [l] 
for documentation of these historic aspects). Interest in 
the copper component was renewed in the 1950s even 
if it remained controversial for another 20 years. With 
the application of the EPR technique, starting in 1959, 
a picture gradually evolved in which the functional unit 
of the oxidase contains 3 redox centers, cytochrome a 
and Cu,, the primary acceptors of electrons from cyto- 
chrome c, and the binuclear cytochrome a&t, unit, 
the O,-reducing site. This picture appeared to be estab- 
lished and generally accepted until 1988, when Kroneck 
et al. [2] suggested that Cu, is really a mixed-valence 
binuclear site. This suggestion was immediately chal- 
lenged [3], but during the last few years it has received 
considerable xperimental support. It is the purpose of 
this contribution to review critically the evidence for 
and against the hypothesis of a binuclear site. 
In 1960 it was demonstrated by EPR that Cu*+ in 
some blue copper proteins (type 1) have unusually small 
hyperfine coupling constants (~10 mT) compared to 
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non-blue proteins (type 2) or synthetic copper com- 
plexes [4]. The EPR spectrum ascribed to Cu’,’ was, 
however, later found to be quite unique, with a hy- 
per-fine coupling constant A, < 4 mT and an anomal- 
ously low g value, more like that of a free radical [5]. 
Kroneck et al. [2] showed that nitrous oxide reductase 
(N,OR) has EPR parameters very similar to those of 
Cug, so that cytochrome oxidase is no longer unique. 
In addition, they found a seven-line hyperfine pattern, 
and this observation formed the basis for their sugges- 
tion that both enzymes contain a binuclear site. The 
presence of a mixed-valence copper pair had, in fact, 
been suggested by Beinert et al. in a long footnote to 
their 1962 paper [5], but they soon retracted this idea. 
In the following, recent studies pertaining to the hy- 
pothesis of a binuclear copper site in cytochrome oxi- 
dase will be briefly discussed. This discussion will be 
preceded by a short presentation of a mononuclear 
model. 
2. A MONONUCLEAR MODEL 
CuA is bound to subunit II of the oxidase. This was 
first suggested [6] on the basis of sequence homologies 
with the blue copper proteins, azurin and plastocyanin, 
and it has now been proven experimentally by genetic 
engineering of the homologous subunit II from a cyto- 
chrome o quinol oxidase [7]. This enzyme lacks Cu,, but 
the site has been restored by the introduction of the 
presumed copper ligands. This also demonstrates that 
the copper-binding region of subunits II has the /3 struc- 
ture of blue copper proteins, the so-called cupredoxin 
fold. 
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Fig. 1. Model of the membrane-anchored subunit II of cytochrome oxidase with a mononuclear Cu, site. Invariant amino acid residues are shown. 
From [S]. 
Subunit II is thought to be anchored to the membrane 
by two transmembrane helices, with the Cu, site located 
outside the membrane, as shown in Fig. 1 [Xl. The struc- 
ture of this region in the COOH-terminal part of the 
peptide chain has been modelled [9,10] on the basis of 
conserved cysteine and histidine residues and the known 
azurin structure. In these models the Cu, site is assumed 
to be mononuclear with two cysteine and two histidine 
residues as ligands (Fig. 1). Such a coordination is sup- 
ported by ENDOR spectra [11,12], and the presence of 
two cysteines may also result in electron delocalization 
away from sulfur onto copper, explaining the free-radi- 
cal character of the EPR spectrum. Some other features 
are, however, better described in terms of a binuclear 
structure (section 3). 
3. EVIDENCE FOR A BINUCLEAR SITE 
3.1. Analytical evidence 
Crucial to the question of whether or not the Cu, site 
is binuclear is the Cu/heme ratio of well-defined oxidase 
preparations. Steffens et al. [13] have reported that bo- 
vine, as well Paracoccus, oxidase contains 3Cu/2Fe, but 
other groups [14,15] have found 2.5Cu/2Fe. A few years 
ago we analyzed a large number of oxidase preparations 
for metals by an X-ray fluorescence method [16]. The 
EPR characteristics, peptide compositions, protein and 
phospholipid contents, as well as the catalytic activities, 
of the samples were also determined. According to our 
results, preparations that were good by other criteria 
(high catalytic activity in particular) always had Cu/Fe 
ratios close to 1.5. It is also notable that the integrated 
intensity of the Cu, EPR signal was 1.0, whereas the 
preparations we made in the 1970s howed an intensity 
of 0.7-0.8 and contained 2.7-2.8Cu/2Fe [17]. In other 
words, more pure preparations have both higher total 
Cu content and higher EPR intensity, which supports 
the binuclear model. 
A blue Cu site has also been created in subunit II of 
cytochrome o, but the Cu.,, mutant always contained 
more Cu/mg protein compared to the blue protein [7] 
(and data presented by M. Saraste at the 7th European 
Bioenergetics Conference). Again, this would agree with 
the binuclear hypothesis. 
3.2. Spectroscopic evidence 
3.2.1. EPR spectroscopy 
Vanngard [18] showed in 1972 that, in a plot of A,, vs. 
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Fig. 2. A plot of A,, vs. g,, for a number of copper proteins. The upper 
points (2) represent ype 2 centers, whereas the lower points (1) are 
for type 1 proteins; the double point in the lower left-hand corner 
shows the parameters for cytochrome oxidase and N,OR. Modified 
from [18]. 
g,,, the parameters for type 1 and type 2 CL?+ centers fall 
in different regions, but Cu, was found to be in a cate- 
gory by itself. As seen in Fig. 2, the parameters for 
N,OR [2] are very close to those for the oxidase, and the 
strong relationship between the sites in the two proteins 
has been further documented by multifrequency EPR 
[19,20] and electron spin echo spectroscopy [21]. These 
data alone are sufficient to say that the sites must be 
nearly identical, and this has been demonstrated also by 
other types of spectroscopy (section 3.2.2) as well as by 
homologies in amino acid sequence [22]. 
Froncisz et al. [23] were the first to show that hy- 
pertme structure can be resolved in the g2 signal of 
oxidized cytochrome oxidase at microwave frequencies 
< 9 GHz. They suggested that this could only in part be 
ascribed to an interaction with an S = 3/2 copper nu- 
cleus, but that an interaction with a proton or another 
paramagnetic site must be involved as well. As a possi- 
bility they considered interaction with cytochrome a, 
and this has also been invoked by other authors [3,24]. 
Such an interaction could also account for another un- 
usual feature of the cytochrome oxidase g2 signal, 
namely that it disappears at temperatures above 150 K 
[25]. The EPR signal from the Cu, mutant of cyto- 
chrome o, which lacks cytochrome a, also disappears at 
this temperature, however, but this protein has, in addi- 
tion, another paramagnet, a type 2 CL?+ ion [7]. It ap- 
pears, on the other hand, rather unlikely that cyto- 
chrome a in another subunit and a type 2 ion in subunit 
II would have exactly the same effect. 
With NzOR a 7-line hyperfine structure can be re- 
solved even at 9 GHz (X-band) [2], and this is most 
readily explained in terms of one unpaired electron in- 
teracting with two S = 3/2 nuclei. Thus, a mixed valence 
binuclear site, [Cu(l.S)...Cu(l.5)], S = l/2, was sug- 
gested for this enzyme, and this hypothesis was 
strengthened by the multifrequency EPR [19,20] and 
spin echo [21] studies already mentioned. Kroneck and 
co-workers [ 19,201 have also investigated the EPR prop- 
erties of cytochrome oxidase at several frequencies, and 
their results are best interpreted in terms of a Cu-Cu 
interaction in both enzymes. In particular, for a 4-line 
pattern from a mononuclear Cu center, no consistent g, 
value could be obtained. The main difference between 
the two enzymes is that hypetine structure cannot be 
resolved at X-band with cytochrome oxidase. It should 
be noted, however, that such structure is seen also at 
X-band in our Cu, mutant (Fig. 3), so perhaps its ab- 
sence in the intact oxidase is caused by a line broadening 
due to interactions with the other paramagnetic enters. 
Simulation on the basis of the binuclear model can 
nicely account for the N,OR spectrum, as shown in Fig. 
3. 
Even if the EPR properties strongly support a binu- 
clear site in both enzymes, such a model cannot explain 
the unusual temperature dependence of the g2 signal 
[25]. Thus, it may still be necessary to invoke an interac- 
tion with another paramagnetic site. Our mutant work 
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Fig. 3. EPR spectra at 9 GHz of the Cu, mutant of cytochrome o [7], 
of cytochrome oxidase and of N,OR [26] as well as a simulated spec- 
trum for a binuclear site in N,OR. 
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[7] speaks against this, however, and this property may 
be the result of a unique binding-site geometry [17]. 
3.2.2. Other spectroscopic properties 
The optical spectrum of the Cu, mutant of subunit 
II in cytochrome o [7] closely resembles that of N,OR 
[26], both having a strong band around 550 nm and a 
weaker one close to 800 nm. This again emphasizes the 
close relationship between the copper sites in these two 
enzymes, which has also been demonstrated by MCD 
measurements [26-281. Thus, if the site in N20R is binu- 
clear, then the Cu, site is so as well. Even if this is not 
definitely established, it certainly offers the best expla- 
nation for the 7-line hypertine structure in the EPR 
spectrum (section 3.2.1). 
The MCD results indicate that 2 cysteine residues are 
associated with the Cu, site [28], and this has also been 
demonstrated by EXAFS data [29,30]. These findings 
would be consistent with a mononuclear model (section 
2), but they do not exclude a binuclear center. In the 
latter case, the two cysteines would interact with two 
copper ions, as suggested in a model by Zumft et al. [22] 
(section 4). 
4. CONCLUDING REMARKS 
Unfortunately it does not appear possible to us to 
state with absolute certainty that Cu, constitutes a 
mixed-valence binuclear site, but the weight of evidence 
is in favor of this hypothesis. Particularly strong sup- 
port comes from the analytical data (section 3.1) and the 
multifrequency EPR studies (section 3.2.1). 
For the binuclear model to be acceptable, it must be 
consistent with the amino acid sequence information 
[6,22]. It is possible to associate the conserved cysteine 
and histidine residues with two copper ions rather than 
with one, as in the mononuclear model [9,10]. This 
has, for example, been done in a model formulated by 
Antholine et al. 1201, partly on the basis of suggestions 
by Farrar et al. [26]. They propose the following struc- 
ture: N(His)-S(Cys)-[Cu(l.5)-S(Cys)-Cu(l.5)]-N(His)- 
S(Met), with a cysteine S serving as the bridging ligand. 
The 7-line hyperfine pattern requires a structure with a 
certain symmetry, but this does not have to be absolute 
[22], so the model is feasible. As an alternative bridging 
ligand, a carboxylate group was suggested, since there 
is a conserved aspartate residue separated by one amino 
acid from one of the ligand histidines. 
In conclusion, we think there is strong support for a 
mixed-valence binuclear site in N,OR as well as in cyto- 
chrome oxidase, and such a model is consistent with all 
spectroscopic and structural infomation. 
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